Jun Jeon
Principal at Khosla Ventures
San Francisco Bay Area
Overview
Work Experience
Principal
2023 - Current
Investor
2021 - 2023
Partnering with entrepreneurs to build impactful, enduring companies.
Khosla Ventures provides venture assistance to entrepreneurs in AI, sustainability, enterprise, consumer, health and frontier technologies.
Raised $1,500,000.00 from Raj Sareen.
Venture Fellow
2021 - 2021
Computational bio + lab-enabling technologies + healthcare / investing + ideating NewCo
AlleyCorp is an early stage venture fund and incubator that founds and funds transformative companies, primarily in New York.
New Product Opportunities
2021 - 2021
Looking at the intersection of biology and commercial impact
Octant Bio is a developer of synthetic technology used to improve health and treat disease.
Raised $115,000,000.00 from What If Ventures, Allen & Company, Bristol-Myers Squibb, Andreessen Horowitz, Fifty Years, Catalio Capital Management, Bioverge and Flucas Ventures.
Fellow / AVP of Startup Sourcing
2020 - 2021
Private equity fund in cybersecurity / managed IT services (healthcare focused)
A highly competitive leadership development program comprised of exceptional graduate students at top universities
Co-Founder / Co-Managing Director
2020 - 2021
bio-launch.com - later became Nucleate Philly Accelerating biotech venture formation from the ground up at the Unversity of Pennsylvania.
Co-Managing Director and Co-founder of Philadelphia Chapter
2021 - 2021
Penn Bio Launch became Nucleate Philly Founding Co-Managing Directors with Eric and Sireesh, and oversaw leadership transition to the new org
a collaborative venture program enabling the formation of biotechnology companies addressing climate & sustainability challenges
Business Development
2020 - 2020
Leveraging pharmacy infrastructure towards new growth opportunities.
Oshi Health is a digital health platform that provides personalized support and resources for people with digestive health conditions.
Raised $119,500,000.00 from Takeda Digital Ventures, Bessemer Venture Partners, CVS Health Ventures, Frist Cressey Ventures, Flare Capital Partners and Oak HC/FT.
Healthcare Private Equity Intern
2020 - 2020
• Roll-up acquisitions in private healthcare practices
Project Manager
2016 - 2020
• [EHR/eCRF data management] Phase 3 Remdesivir (COVID19 anti-viral) clinical trial at Penn • [Project lead] Cochlear implant candidacy evaluation process quality improvement • [Project lead] Brain tumor labeling with fluorescent dye for accurate resection
Penn Medicine is the medical school that provides medical research and education services to students.
Raised $70,900,000.00 from Warren Alpert Foundation, National Cancer Institute, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health and National Institutes of Health.
Immuno-Oncology and RNA Interference (MRSP Fellow)
2019 - 2020
• Highly selective NIH-hosted research program for 50 medical students from across the US. • Focus on novel cancer therapeutics discovery pipeline, large genomic data analysis, immunotherapy, and hearing research.
National Institutes of Health is a biomedical research facility that focuses on biomedical and health-related research.
Raised $5,000,000.00 from National Institute of Allergy and Infectious Diseases.